Back to results
US 2024/0408110 A1Published application
Pharmaceutical hydrocortisone solution for injection device
AssigneeCrossject
InventorsLaurette VINCENT, Olivier LACOMBE, Marion IGUINIZ
Life of this patent
Estimating the term…
Abstract
A pharmaceutical solution of hydrocortisone includes in mg per 1 mL of solution: between 150 mg and 170 mg of hydrocortisone or a pharmaceutically acceptable salt thereof in equivalent amount, between 2 mg and 7.5 mg of monothioglycerol, and Qsp 1 mL of solvent. The solution is used in the treatment of acute adrenal insufficiency and asthma and concerns an injection kit including an injection device and this pharmaceutical solution.
Claims12
A pharmaceutical hydrocortisone solution which comprises in mg per 1 mL of said solution at least:
- between 150 mg and 170 mg of hydrocortisone or a pharmaceutically acceptable salt thereof in equivalent amount,
- between 2 mg and 7.5 mg of monothioglycerol,
- Qsp 1 mL of solvent, «Qsp» being the abbreviation of «amount sufficient for» meaning that the amount of solvent is such that the volume of the solution is completed to 1 mL.
Dependencies are inferred from the claim text.